Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Hurst
Christopher Hurst
Biogen Idec
Medicine
Toxicology
Pharmacology
Toxicity
Clinical trial
3
Papers
282
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
2016
Neurology and Therapy
Ralf Gold
Dusan Stefoski
Krzysztof Selmaj
Eva Havrdova
Christopher Hurst
Joan Holman
Belen Tornesi
Surekha Akella
Peter McCroskery
Show All
Source
Cite
Save
Citations (14)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
2009
Regulatory Toxicology and Pharmacology
Rafael Ponce
Leslie Abad
Lakshmi Amaravadi
Thomas Gelzleichter
Elizabeth R. Gore
James Green
Shalini Gupta
Danuta J. Herzyk
Christopher Hurst
Inge Ivens
Thomas T. Kawabata
Curtis Maier
Barbara Mounho
Bonita Rup
Gopi Shankar
Holly W. Smith
Peter Thomas
Dan Wierda
Show All
Source
Cite
Save
Citations (209)
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
2008
Regulatory Toxicology and Pharmacology
Janet Clarke
Christopher Hurst
Pauline L. Martin
John L. Vahle
Rafael Ponce
Barbara Mounho
Shawn M. Heidel
Laura Andrews
Theresa Reynolds
Joy Cavagnaro
Show All
Source
Cite
Save
Citations (59)
1